
51 - 200 Mitarbeiter
Gegründet 2019
🧬 Biotechnologie
💊 Pharmazie
🔬 Wissenschaft
💰 €85.000.000 Series B im 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics ist ein patientenorientiertes, biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung von Zelltherapien für Patienten mit Autoimmunerkrankungen konzentriert. Das Unternehmen ist Vorreiter bei CAR-T-Zelltherapien, indem es die transformativen Kräfte von T-Zellen nutzt, um möglicherweise eine anhaltende, behandlungsfreie Remission für Autoimmunerkrankungen zu bieten. Der führende CAR-T-Zelltherapie-Kandidat von Kyverna, KYV-101, befindet sich in klinischen Studien zur Behandlung verschiedener Autoimmunerkrankungen, darunter Multiple Sklerose, Myasthenia gravis, systemische Sklerose und Lupus-Nephritis. Ihre Pipeline umfasst innovative chimäre Antigenrezeptor (CAR)-T-Zelltherapien in sowohl autologen als auch allogenen Formaten, die auf B-Zell-getriebene Autoimmunerkrankungen abzielen.
🕒 vor 16 Tagen
🗣️🇺🇸🇬🇧 Englisch erforderlich
Verbessern Sie Ihre Chancen auf ein Vorstellungsgespräch, indem Sie Ihre Lebenslauf-Bewertung vor der Bewerbung überprüfen.

51 - 200 Mitarbeiter
Gegründet 2019
🧬 Biotechnologie
💊 Pharmazie
🔬 Wissenschaft
💰 €85.000.000 Series B im 2022-01
Biotechnology • Pharmaceuticals • Science
Kyverna Therapeutics ist ein patientenorientiertes, biopharmazeutisches Unternehmen im klinischen Stadium, das sich auf die Entwicklung von Zelltherapien für Patienten mit Autoimmunerkrankungen konzentriert. Das Unternehmen ist Vorreiter bei CAR-T-Zelltherapien, indem es die transformativen Kräfte von T-Zellen nutzt, um möglicherweise eine anhaltende, behandlungsfreie Remission für Autoimmunerkrankungen zu bieten. Der führende CAR-T-Zelltherapie-Kandidat von Kyverna, KYV-101, befindet sich in klinischen Studien zur Behandlung verschiedener Autoimmunerkrankungen, darunter Multiple Sklerose, Myasthenia gravis, systemische Sklerose und Lupus-Nephritis. Ihre Pipeline umfasst innovative chimäre Antigenrezeptor (CAR)-T-Zelltherapien in sowohl autologen als auch allogenen Formaten, die auf B-Zell-getriebene Autoimmunerkrankungen abzielen.
• Lead the preparation and review of quarterly and annual SEC filings, including Forms 10-Q, 10-K, 8-K, S-8, supporting disclosures, and related tie-out documentation and reporting workbooks • Prepare and review key financial statement areas and disclosures, including: • - Lease accounting (ASC 842) • - Share-based compensation (ASC 718) • - Available-for-sale investments • - Statement of cash flows • - Stockholders’ equity roll forwards • Manage the Company’s quarterly and annual reporting calendar and coordinate cross-functional deliverables with Legal, Investor Relations, Finance, and external stakeholders to ensure timely and accurate SEC filings • Serve as a key point of contact for external auditors and SOX auditors in connection with quarterly reviews, annual audits, and ongoing compliance activities • Assist in the preparation of Audit Committee and Disclosure Committee materials and presentations, as needed • Lead and coordinate SOX compliance initiatives, partnering with internal process owners, external auditors, and SOX consultants to support ongoing compliance and control effectiveness • Maintain and enhance SOX documentation, including narratives, process flows, and risk control matrices (RCMs) • Research, analyze, and document technical accounting conclusions under U.S. GAAP for complex and non-routine transactions • Prepare technical accounting memoranda and supporting analyses related to lease accounting under ASC 842, including lease modifications and reassessments • Partner with the VP, Corporate Controller and third-party advisors on technical accounting assessments related to financing transactions, strategic agreements, and other complex accounting matters • Support operational and cross-functional teams with technical accounting guidance related to inventory, cost capitalization, debt accounting, collaboration agreements, new accounting pronouncements, and other business initiatives • Perform technical accounting calculations and analyses related to share-based compensation accounting under ASC 718, including equity award modifications and Black-Scholes fair value calculations • Conduct quarterly contract reviews to identify accounting implications and ensure appropriate accounting treatment and documentation • Support selected stock administration and payroll-related accounting review activities • Assist with accounting and reporting for debt and equity financings, licensing and collaboration agreements, and other strategic transactions • Participate in process improvement initiatives, automation efforts, and system implementations to support scalability and operational efficiency within a growing public company environment • Contribute to ad hoc analyses, special projects, and broader Finance organization initiatives, as needed
• Bachelor’s degree in Accounting or Finance required • Active CPA license required • 10+ years of progressive accounting experience, including experience serving SEC registrants within public accounting and/or accounting advisory environments • Big Four or national public accounting firm experience strongly preferred • Strong technical knowledge of U.S. GAAP, SEC reporting requirements, and public company compliance obligations • Demonstrated experience preparing technical accounting memoranda and analyzing complex accounting transactions • Experience supporting SOX 404(b) compliance programs and internal control frameworks • Biotechnology, pharmaceutical, or life sciences industry experience preferred, but not required • Strong Excel, financial systems, and reporting tool experience; Workiva experience is a plus • Excellent organizational, project management, and communication skills with the ability to manage multiple priorities in a fast-paced environment • Collaborative, team-oriented mindset with a willingness to roll up sleeves and support broader team initiatives • Ability to remain highly detail-oriented, hands-on, and execution-focused while operating strategically in a growing organization
• bonus • benefits • participation in Company’s stock plan
Jetzt Bewerben🕒 vor 16 Tagen
Accounting Manager overseeing compliance and controls at MASA, a leader in emergency medical transportation insurance. Leading financial reporting, audits, and tax processes with significant business impact.
🇺🇸 Vereinigte Staaten – Remote
⏰ Vollzeit
🟠 Senior
🔴 Experte
🧾 Leiter Rechnungswesen
🦅 H1B-Visum-Sponsor
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 16 Tagen
Senior Accounting Manager responsible for managing US accounting functions. Join PolyAI to improve financial operations with AI in a SaaS environment.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 17 Tagen
Senior Accountant managing client accounts across various industries in a remote capacity. Responsible for financial accuracy, insights, and supporting the Controller team.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 17 Tagen
Senior Accounting Manager overseeing accounting operations while handling key accounting tasks at Patch My PC. Supporting financial processes and collaborating with finance teams to enhance efficiency.
🗣️🇺🇸🇬🇧 Englisch erforderlich
🕒 vor 17 Tagen
Accounting Operations Analyst managing contracting needs for shared service departments. Collaborating with internal stakeholders and handling budgetary matters at Stride, Inc.
🇺🇸 Vereinigte Staaten – Remote
💵 $51.044 - $70.000 / Jahr
⏰ Vollzeit
🟡 Mittelstufe
🟠 Senior
🧾 Leiter Rechnungswesen
🗣️🇺🇸🇬🇧 Englisch erforderlich